Our results showed that LL‐Z1640‐2 and patulin are promising compounds that decrease ZIC5 expression levels and induce apoptosis in various cancer cells, including melanoma, BRAF‐inhibitor resistant melanoma, pancreatic cancer and cholangiocarcinoma cells. This evidence concerns the gene ZIC5 and pancreatic neoplasm.